AlphaYouJI
Congress trade
Sen. James Inhofe (R-OK) sold $15K-$50K of Editas Medicine, Inc. (EDIT) stock
James Inhofe, U.S. Senator (R-OK), disclosed a sale of Editas Medicine, Inc. (EDIT) stock worth $15K-$50K in a STOCK Act filing on Feb 25, 2019.
The trade happened on Feb 4, 2019, 21 days before it was made public.
EDIT has moved -88.0% since the trade date, from $21.91 to $2.62 (Oct 2, 2026 close).
- Traded
- Feb 4, 2019
- Disclosed
- Feb 25, 2019
- Filing delay
- 21 days
- Price since
- -88.0%
- Source
- STOCK Act disclosure
Other trades in this disclosure (1)
More EDIT insider and Congress trades
From a public STOCK Act disclosure, linked above. Not investment advice, and not a recommendation to buy or sell.